Navigation Links
Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013
Date:7/29/2013

WASHINGTON, July 29, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced it will release results for the second quarter of 2013 on Wednesday, July 31, 2013, before the market opens.

The Company will host a conference call at 10:00 AM ET on Wednesday, July 31, 2013, during which Vanda management will discuss the financial results.  To participate in the conference call, please dial 1-888-895-5479 (domestic) or 1-847-619-6250 (international) and use passcode 35347357.

The conference call will be broadcast simultaneously and archived on the Company's website, www.vandapharma.com.  Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, July 31, 2013, beginning at 12:00 PM ET and will be accessible until Wednesday, August 7, 2013, at 5:00 PM ET.  The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers.  The passcode number is 35347357.

ABOUT VANDA PHARMACEUTICALS INC.:

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.  For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Company Contact:
Jim Kelly
Senior Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com


'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
2. Vanda Pharmaceuticals, Inc. Sued by Investor
3. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
4. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
5. Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
6. Vanda Announces Submission To FDA Of A New Drug Application For Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
7. Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
8. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
9. Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013
10. Vanda Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
11. Vanda Reports Successful Completion Of Pre-NDA Meeting With FDA On Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  A new genetic test has been ... individuals who carry HLA-B*15:02 and who ... potentially deadly side effect of certain medications used ... HLA-B*15:02 is strongly associated with life-threatening ... and toxic epidermal necrolysis in patients treated with ...
(Date:3/23/2017)... March 23, 2017 On ... the trading session at 5,821.64, up 0.48%; the ... finish at 20,661.30; and the S&P 500 closed ... based as six out of nine sectors ended ... initiated reports coverage on the following Medical Instruments ...
(Date:3/23/2017)... 2017 Pre-market today, Stock-Callers.com has issued ... AGN), Horizon Pharma PLC (NASDAQ: HZNP), and Evoke Pharma Inc. ... part of the Healthcare sector, which was slightly higher in ... the NYSE Health Care Index adding about 0.1% in value, ... also were up nearly 0.1% as a group. Learn more ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... 2017 , ... On 2 March 2017, the United States ... Command’s Patriot Award. The award was presented by the USSOCOM Commander, General Raymond ... its significant and enduring support to the command. , Accepting the award ...
(Date:3/23/2017)... ... March 23, 2017 , ... The Boulevard is honored to host Shriners and ... will be located in the Main West Entrance of The Boulevard (in front of ... appointment is necessary and each child with a parent or guardian will be photographed ...
(Date:3/23/2017)... ... ... News Advisory/Interview Opportunity , After six years of advocacy, testimony and grassroots organizing, ... health and the environment and is calling on the United States to follow the ... of European citizens, the European Union (EU) will, beginning next year, ban the use ...
(Date:3/23/2017)... ... ... Woman Be Ye Healed-Passing On A Legacy”: a call to heal the wounded Church. ... author, Desiree M Webb, a registered nurse, minister of music, speaker, songwriter, recording artist, ... husband, Paul, for over twenty-nine years. Desiree enjoys writing, beach trips, ministering in ...
(Date:3/23/2017)... ... March 23, 2017 , ... Ogden ... innovative patient - centric payment system, to expand its focus on patient care ... patient financial experience. , “At Ogden Clinic, we are working to become ...
Breaking Medicine News(10 mins):